Compounded Testosterone Injection Recalled Due to Lack of Sterility Assurance
Tailor Made Compounding is recalling 176 vials of testosterone cypionate/propionate injectable due to lack of assurance of sterility. The product was distributed nationwide.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall of an injectable medication with lack of sterility assurance, representing a significant risk of serious infection. No illnesses or deaths are reported in the source, making this a theoretical risk-of-harm situation that meets the High severity threshold.
Plain-English summary
Tailor Made Compounding (TMC Acquisition LLC) is recalling 176 vials of Testosterone Cypionate/Propionate 180/20mg/ml, a compounded injectable medication. The recall affects two vial sizes: 5 mL-vials and 10 mL-vials packaged for room temperature storage. Affected batches include: 11042102A1 (expiration 4/30/2022), 12072135A1 (expiration 6/5/2022), 01142228A1 (expiration 7/13/2022), and 02182231A1 (expiration 8/17/2022).
The recall is due to lack of assurance of sterility. For injectable medications like testosterone, sterility assurance is critical because contaminated injectables can introduce serious infections.
The affected product was distributed nationwide throughout the United States and Puerto Rico. Patients and healthcare providers who received testosterone from these batches should consult with their prescribing healthcare provider about this recall.
Consumers should discontinue use of the affected product and contact their healthcare provider about alternative testosterone preparations. The FDA has classified this as a Class II recall.
The recalled product
- Product
- Testosterone Cypionate/Propionate 180/20mg/ml, a) 5 mL-vial, b) 10 mL-vial, Room temperature, Tailor Made Compounding
- Manufacturer
- TMC Acquisition LLC dba Tailor Made Compounding
- Category
- Drug — Injectable / Compounded
- Affected units
- 176
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (10)
- Batch#: a)11042102A1
- Exp 4/30/2022
- 12072135A1
- Exp 6/5/2022
- 01142228A1
- Exp 7/13/2022
- 02182231A1
- Exp 8/17/2022
- b)11042102A1
- Exp 7/13/2022.
Distribution
Part of a larger recall action
This product is one of 52 recalled by TMC Acquisition LLC dba Tailor Made Compounding under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 52 products in this recall →Related recalls
Same manufacturer · TMC Acquisition LLC dba Tailor Made Compounding
See all →- HighDexpanthenol Preservative Free Injectable Recalled Due to Sterility Assurance Failure
FDA (Drugs) · 2022-07-20
- HighHydroxocobalamin Compounded Injections Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2022-07-20
- HighTailor Made Compounding Recalls Glycyrrhizic Acid Injectable for Lack of Sterility Assurance
FDA (Drugs) · 2022-07-20
- HighFDA Recalls Tailor Made Compounding GAC Injectable Vials for Lack of Sterility Assurance
FDA (Drugs) · 2022-07-20
- HighEstradiol Cypionate Injectable Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2022-07-20
Same hazard · sterility assurance
See all →- HighArrowhead DE LLC Recalls Arrow-LOK Implants Due to Sterility Assurance Concerns
FDA (Devices) · 2026-08-26
- SevereChloraPrep One-Step Applicators Recalled for Potential Packaging Seal Defects
FDA (Drugs) · 2026-07-22
- SeverePemetrexed for Injection Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2026-07-15
- SevereChloraPrep One-Step Applicators Recalled Due to Sterility Assurance Failure
FDA (Drugs) · 2026-07-08
- SevereArrow drainage and thoracentesis kits contain recalled supplier drugs
FDA (Devices) · 2026-06-24